The Bellvitge University Hospital, is a public hospital located in town of l'Hospitalet de Llobregat, with an outstanding care, teaching and researching activity. It is specialized in high complexity medical care. It offers all the medical specialties, except for pediatrics and obstetrics.

During the past decade, Bellvitge University Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 5 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bellvitge University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 2 trials sponsored, "Hospital Universitari de Bellvitge" with 2 trials sponsored and "Institut d'Investigació Biomèdica de Bellvitge" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bellvitge University Hospital" #1 collaborator was "Asociacion Española de Coloproctologia" with 1 trials as a collaborator, "Asociación Española de Cirugía" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cubist Pharmaceuticals LLC" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Bellvitge University Hospital" are "Acute Stroke" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Atrial Fibrillation" (1 trials) and "Bacteremia Caused by Gram-Negative Bacteria" (1 trials). Many other conditions were trialed in "Bellvitge University Hospital" in a lesser frequency.

Most popular intervention types in "Bellvitge University Hospital" are "Drug" (21 trials), "Device" (6 trials), "Biological" (5 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "IB1001" (2 trials), "(BMS/DES)" (1 trials), "Angio" (1 trials) and "Antipseudomonal beta-lactam antibiotic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bellvitge University Hospital" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Bellvitge University Hospital". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bellvitge University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bellvitge University Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".